Device Trial Radar · NCT07949747
Evaluating Pulsed Dye Laser Treatment Parameters on Clearance of Vascular Indications
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
25
Planned (sponsor's estimate)
Start
Jul 6, 2026
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- University of California, IrvineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Candela Corporation
- First posted
- Nov 19, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this prospective clinical study is to evaluate pulsed dye laser treatment parameters on the clearance of vascular indications, including rosacea and port wine capillary malformations. The main question it aims to answer is: \- Does the use of post-cooling, compared with no post-cooling, affect patient-reported pain scores and treatment outcomes after one treatment session? Participants will: * Receive PDL treatment according to the study protocol. * Complete all required follow-up visits and questionnaires. * Undergo OCT imaging assessments, as applicable to the study protocol.
Conditions
- Rosacea
- Scars
- Port Wine Capillary Malformations
Interventions
Laser with DCD Pre- and Post-CoolingDevice
Study subject will undergo informed consent procedure, eligibility screening, and enrollment to receive treatment to one or more treatment areas depending on the presenting condition and principal investigator assessment. Study subject may receive 1-3 treatments within the study with 4-12 weeks between each treatment visit. Two test areas will be determined in the area(s) of the vascular condition. Each lesion will serve as its own control, since it is divided in half and each side receives a different set of laser settings. The following laser settings will be applied: Area 1: Spot size 7-15mm; pulse duration 1.5-10 ms; fluence 5-8 j/cm2; cooling settings 10-30/20-30/10-20 ms
Laser with Standard DCD Pre-Cooling OnlyDevice
Study subject will undergo informed consent procedure, eligibility screening, and enrollment to receive treatment to one or more treatment areas depending on the presenting condition and principal investigator assessment. Study subject may receive 1-3 treatments within the study with 4-12 weeks between each treatment visit. Two test areas will be determined in the area(s) of the vascular condition. Each lesion will serve as its own control, since it is divided in half and each side receives a different set of laser settings. The following laser settings will be applied: Area 2: Spot size 7-15mm; pulse duration 1.5-10 ms; fluence 5-8 j/cm2; cooling settings 10-30/20-30/0 ms
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Effect of Pre- and Post-Cooling on Patient Reported Discomfort as Evaluated by Responses to Two-Part Post-Treatment QuestionnaireTime frame: From date of first treatment until study completion, assessed up to 52 weeks.
- Patient-Reported Evaluation of Improvement as Assessed by Participant QuestionnaireTime frame: From date of first treatment until study completion, assessed up to 52 weeks.
- Blinded Physician EvaluationTime frame: Up to 52 weeks.
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California, Irvine
Irvine, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.